BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.8 EUR
0.72%
Market Closed
Updated:
May 2, 2024
P/E
Price to Earnings
Price to Earnings
-7.3
Current
-19.4
Median
21.7
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-7.3
Market Cap
/
61.2m
Net Income
-8.4m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| DE |
|
BRAIN Biotech AG
XETRA:BNN
|
61.2m EUR | -7.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
12.1T JPY | 22.6 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
76.7B USD | 31.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
64.3B USD | 46.8 | |
| CH |
|
Sika AG
SIX:SIKA
|
42.2B CHF | 39.8 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
36.4B CHF | 40.8 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
279.8B CNY | 16.6 | |
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
33.6B USD | 79.4 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.8T INR | 50.7 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
30.5B USD | 21.7 | |
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
28.1B EUR | 13.2 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-12.8
2-Years Forward
P/E
17.6
3-Years Forward
P/E
5.8
You don't have any saved screeners yet
